FIGURE 3.
Predicted and observed mean plasma concentration‐time profiles of milademetan in the presence of multiple daily doses of fluconazole, erythromycin, and verapamil
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.